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 2 
Abstract 19 
Parathyroid hormone related protein (PTHrP) and its receptor have well established roles in the 20 
development and regulation of many tissues, including bone and mammary gland. The objectives of 21 
this study were: 1) to characterize the distribution of mRNAs encoding parathyroid hormone (PTH)-22 
related protein (PTHrP) and receptor (PTHR) in bovine ovary; 2) to characterize the distribution of 23 
PTHrP and PTHR polypeptides in bovine ovary; and 3) to examine the influences of PTHrP (1-141) 24 
treatment during bovine oocyte maturation in vitro on blastocyst development.  mRNAs encoding 25 
PTHrP and PTHR were detected by in situ hybridization methods in oocytes, and granulosa cells in 26 
all follicles from primordial to large antral. PTHrP and PTHR polypeptides displayed distinct 27 
distribution patterns with PTHrP polypeptides primarily confined to oocytes from primordial to large 28 
antral follicles. PTHrP polypeptides were detectable but at a reduced level in ovarian stroma and in 29 
granulosa and thecal layers.  PTHR polypeptides were detected in oocytes of all follicular stages but 30 
were predominantly found in ovarian stroma, granulosa and theca follicular layers. Supplementation 31 
of serum-free cSOFMaa oocyte maturation medium with PTHrP (1-141) resulted in a concentration- 32 
dependent increase in development to the blastocyst stage in vitro. The results suggest that granulosa 33 
cells may be a primary site of PTHrP production and release. Oocytes from all follicular stages 34 
stained strongly for PTHrP polypeptides and PTHrP enhanced development to the blastocyst stage in 35 
vitro.   36 
 37 
 38 
 39 
  40 
41 
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Introduction 42 
With the characterization of effective, defined and protein-free media to support the 43 
maturation of mammalian oocytes in vitro it is now possible to examine the roles played by specific 44 
hormone and growth factor modulators during oocyte maturation and upon subsequent early 45 
embryonic development (Saeki et al., 1991; Gardner, 1994; Eckert et al., 1995; Keskintepe and 46 
Brackett, 1996; Hill et al., 1997; Avery et al., 1998; Krishner and Bavister, 1999; Watson et al., 47 
2000). Parathyroid hormone related protein (PTHrP) was originally isolated from patients suffering 48 
from humoral hypercalcemia of malignancy (Spiegel et. al., 1983; Strewler et. al., 1987; Stewart et. 49 
al., 1987).  As its name suggests, this molecule shares structural homology with parathyroid  50 
hormone (PTH) (Stewart et. al., 1987; Horiuchi et. al. 1987), which enables PTHrP and PTH to 51 
signal through a common PTH/PTHrP receptor  (Rodan, et. al., 1988; Abou-Samra, et. al., 1992). 52 
While PTH is predominantly (if not exclusively) produced by the parathyroid glands, PTHrP is 53 
synthesized by many tissues including skin, brain, pancreas, adrenal glands, smooth muscle, heart, 54 
lung, lactating breast, uterus, ovary and placenta (Urena et. al., 1993; Tian et. al., 1993; Lee et al., 55 
1995; Weaver et. al., 1995; Downey et. al., 1997; Li  et. al., 1995; Vasavada, et. al., 1998; Curtis et. 56 
al., 1998; Ferguson et. al., 1998; Moseley and Gillespie, 1995; Gutmann et. al., 1993). PTHrP  is 57 
predominantly a paracrine/autocrine regulator of cellular growth and differentiation (Moseley and 58 
Gillespie, 1995). The expression and distribution of gene products encoding PTHrP and the PTHR 59 
have not been investigated within the bovine ovary. The objectives of the present study were: 1) to 60 
characterize the distribution of mRNAs encoding parathyroid hormone (PTH)-related protein 61 
(PTHrP) and receptor (PTHR) in the bovine ovary; 2) to characterize the distribution of PTHrP and 62 
PTHR polypeptides in the bovine ovary; and 3) to examine the influences of PTHrP (1-141) 63 
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treatment during bovine oocyte maturation in vitro on blastocyst development.     64 
Materials and methods 65 
Detection of PTHrP and PTHR mRNAs in Bovine Ovary by in situ Hybridization 66 
Bovine ovaries were collected at a local slaughterhouse and were quartered and placed 67 
into 4% paraformaldehyde in phosphate buffered saline (PBS) pH 7.2 fixative for overnight 68 
fixation. Ovarian pieces were then processed for routine paraffin embedding.  In situ 69 
hybridization (ISH) was carried out using biotin-labeled sense and antisense riboprobes and the 70 
Genpoint CSA kit (Dako Diagnostics, Mississauga, ON, Canada) as described (Watson, et. al., 71 
2000a; Watson, et. al., 2000b). Labeled riboprobes were prepared from plasmids containing 72 
either a 2Kb cDNA corresponding to rat PTHR mRNA (Pausova, et.al., 1994; Amizuka, et.al., 73 
1997) or a 0.7 Kb cDNA corresponding to rat PTHrP mRNA (Yasuda et.al., 1989) using T3 and 74 
T7 RNA polymerases (Gibco, Burlington, ON, Canada) and a nucleotide labeling mix containing 75 
biotin-16-UTP (Boerhinger-Mannheim, Burlington, ON, Canada). Tissue sections were 76 
deparaffinized and rehydrated in a standard xylene and alcohol series and ISH performed 77 
according to the manufacturer’s directions. Briefly, slides were heated in Target Retrieval 78 
Solution and proteinase K to undo protein cross-links caused by fixation. Endogenous peroxidase 79 
activity was quenched in 0.3% hydrogen peroxide in methanol for 50 min at room temperature. 80 
Sections were hybridized for 2 hours at 42oC with 5 ng/ml biotin-labeled riboprobe in the 81 
supplied RNA hybridization buffer. After stringent washing at 55oC, sections were treated with 82 
successive incubations in primary streptavidin-horse radish peroxidase, biotinyl-tyramide 83 
solution and secondary streptavidin-horse radish peroxidase (Dako) for 15 minutes each at room 84 
temperature. Color (golden-brown) was developed with the supplied diaminobenzidine diluted as 85 
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directed (Dako) and sections counterstained with Carazzi’s haematoxylin (blue) prior to 86 
dehydration and mounting. We have employed this procedure using the same cDNAs to generate 87 
riboprobes to localize PTHrP and PTHR mRNAs in rat tissues (including ovary) in previous 88 
studies (Watson, et. al., 2000a; Watson, et. al., 2000b). 89 
 90 
Immunocytochemical (ICC) Detection of PTHrP and PTHR polypeptides in Bovine Ovary 91 
ICC was performed as described (Watson et. al., 1995; Watson et. al., 2000a; Watson et. al., 92 
2000b). Briefly, tissue sections (as described above) were deparaffinized and rehydrated in a standard 93 
xylene-ethanol series,  post-fixed in 4% paraformaldehyde for 15 minutes and incubated for 10 94 
minutes with 10 g/ml proteinase K (Gibco, Burlington, ON, Canada) at room temperature to 95 
retrieve fixation-concealed antigens. Sections were stabilized in 4% paraformaldehyde for a further 96 
15 minutes before proceeding with the ICC procedure using the Vectastain ABC kit (Vector Labs, 97 
Burlington, ON, Canada) following the manufacturer’s directions. A polyclonal rabbit anti-rat PTHR 98 
antibody was used: antibody PTH-IV raised against a portion of the first extracellular loop 99 
(TLDEARLTEEELH; aa 249-262) (Babco, Berkeley, CA, USA) (Largo, Gomez-Garre, et. al., 1999). 100 
The PTHrP antibody used was a mouse monoclonal raised against amino acids 34-53 of human 101 
PTHrP (Oncogene Research Products, Cambridge, MA, USA). Both antisera are fully characterized 102 
and their specificity for PTHrP and PTHR polypeptides is well-established (Watson et. al, 1999a; 103 
Watson et. al., 1999b; Ferguson et. al., 1998, Largo et. al., 1999).  Primary antibodies were diluted to 104 
100 g/ml in 1% BSA-PBS.  As a control, some sections were treated with PTHR primary antibody 105 
that had been pre-absorbed overnight at 4oC with the appropriate peptide. For the PTHrP antiserum, 106 
control sections were treated with normal mouse serum instead of primary antibody. All sections 107 
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were counterstained with Carazzi’s hematoxylin prior to dehydration and mounting. 108 
 109 
Oocyte Collection, Insemination and Embryo Culture: 110 
Cumulus oocyte complexes (COCs), were collected by razor blade slashing of slaughterhouse 111 
ovaries within 4 h of removal from the animal (Wiemer et al., 1991;Watson et al., 1994). The COCs 112 
were collected in oocyte collection medium (HEPES-buffered TCM-199 + 2% (v/v) NCS; Gibco 113 
BRL, Burlington, ON, Canada) and then were washed 4 times in serum-free medium prior to 114 
placement in oocyte maturation medium. Only denuded oocytes were discarded and a COC selection 115 
strategy was not employed in this study. Following oocyte maturation (see below for specific 116 
experimental conditions), oocytes were inseminated in vitro with frozen thawed bovine semen 117 
(Semex Canada Inc., Guelph, ON, Canada) prepared using a "swim-up" method in Sperm TL 118 
medium (HEPES-buffered modified Tyrodes solution as described in (Parrish et al., 1986). Matured 119 
COCs were washed in sperm TL and placed in equilibrated fertilization drops (50 COCs/ 300 l 120 
drop) composed of bicarbonate-buffered modified Tyrodes solution under light paraffin oil (Parrish 121 
et al., 1986) BDH Inc., Toronto, ON, Canada). COCs and sperm (2.25x105 motile spermatozoa/drop) 122 
were incubated for 18h at 39oC under 5% CO2 in air atmosphere before removal with a fine bore 123 
glass pipette of the cumulus investment including all corona cells. Inseminated oocytes (40-50) were 124 
placed into embryo culture consisting initially of 20 l microdrops of citrate (0.5mM) and 125 
polyvinylalcohol (PVA; 3 mg/ml) supplemented synthetic oviduct fluid medium (cSOFMaa) 126 
(Keskintepe et al., 1995; Kestinkepe and Brackett, 1996; Watson et al., 2000) + 1X non-essential 127 
amino acids (NEA, Sigma-Aldrich Canada Ltd, Oakville, Ontario) and 1X essential amino acids 128 
(MEM, Gibco, BRL) under paraffin oil in a humidified 5% CO2 / 7% O2 / 88% N2 culture 129 
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atmosphere. Two days following initiation of culture, the microdrops were increased in volume by 130 
addition of 20 l of cSOFMaa medium. On days 5 and 7 of culture 20 l of medium was removed 131 
from each and replaced with 20 l of fresh medium, thus keeping the microdrop volume constant for 132 
the remainder of the eight day culture interval. Cleavage and blastocyst frequencies were assessed on 133 
day 3 and 8 post insemination respectively.  134 
 135 
Experimental Design: 136 
A PTHrP concentration experiment ( 0, 10-10  M, 1.59 ng/ml; 10-8 M, 15.9 ng/ml; and 10-6 137 
M, 159 ng/ml PTHrP) was conducted employing a randomized design that allocated equivalent 138 
numbers of non-selected COCs (total number of 442 COCs representing 4 experimental 139 
replicates with 25-30 oocytes allocated to each treatment group per replicate ) to gonadotrophin 140 
and estradiol 17- -free cSOFMaa  oocyte maturation medium employing a 5% CO2 in air 141 
atmosphere at 39oC for 22 h. Following maturation, oocyte pools were inseminated and zygotes 142 
were placed into culture for assessment of frequency of development to the blastocyst stage as 143 
described. 144 
 145 
Statistical Analysis: 146 
Culture data were analyzed using the SigmaStat  (Jandel Scientific) software package.  147 
One-way analysis of variance (ANOVA), followed by pairwise multiple comparisons 148 
(Bonferronis Method), were used for analysis of differences in the means for two or more 149 
populations.  Differences of P 0.05 were significant differences.  150 
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Results  151 
Detection of PTHrP and PTHR mRNAs in Bovine Ovary by in situ Hybridization 152 
PTHrP and PTHR mRNAs were localized in bovine ovarian tissue with biotinylated 153 
antisense riboprobes. Experiments were applied to tissue sections obtained from three bovine 154 
ovaries collected at slaughter and all in situ experiments were conducted a minimum of three 155 
times. In total over 100 follicles including stages from primordial to large antral follicles were 156 
examined. mRNAs encoding PTHrP were detected by in situ hybridization methods in oocytes, 157 
and granulosa cells in all follicles from primordial to large antral (Fig. 1 B, D, F, E). The 158 
granulosa cells of antral follicles displayed more intense signals for PTHrP mRNA (Fig 1E). A 159 
positive signal for PTHrP mRNAs was observed in thecal layers of larger follicles and in ovarian 160 
stroma in general (Figure 1 B,D,F, E). The signal observed for PTHrP sense controls (Fig. 1 A, 161 
C) was very low and indicated the specificity of the antisense PTHrP riboprobe.  mRNAs 162 
encoding PTHR were detected in oocytes and granulosa cells in all follicles from primordial to 163 
large antral (Fig2 B,D,F, E). A positive signal for PTHR mRNA was observed in thecal layers of 164 
larger follicles and in ovarian stroma (Fig. 2 B,D, E,F).  Sense PTHR mRNA controls displayed a 165 
very low background signal in granulosa and thecal layers (Fig. 2 A,C).  166 
 167 
Immunocytochemical Detection of PTHrP and PTHR polypeptides in Bovine Ovary 168 
PTHrP and PTHR  immunoreactivity was studied in intact bovine ovarian tissue sections 169 
to assess the distribution of these polypeptides within the bovine ovary. PTHrP and PTHR 170 
polypeptides displayed distinct distribution patterns with PTHrP polypeptides primarily confined 171 
to oocytes from primordial to large antral follicles (Fig. 3 B,D,F). PTHrP polypeptides were also 172 
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localized to a lesser extent in ovarian stroma and reduced signals were obtained in granulosa  173 
cell and thecal layers (Fig. 3 B,D, E, F). PTHrP immuno-specificity was determined by 174 
demonstrating a very low background signal in normal mouse serum-treated tissue sections (Fig. 175 
3 A,C). PTHR polypeptides were detected in oocytes of all follicular stages (Fig 4, B, D, F). 176 
However, the most intense signals for PTHR polypeptides were localized to ovarian stroma, 177 
granulosa cell and thecal follicular layers (Fig 4 B,D,E, F). Pre-absorbed antibody controls 178 
indicated a high level of specificity for the PTHR immunolocalization signal (Fig 4A, C). 179 
 180 
Influence of PTHrP during Oocyte Maturation on Development of Bovine Zygotes In vitro 181 
cSOFMaa culture medium employed for bovine oocyte maturation was supplemented 182 
with PTHrP and influences on development to the blastocyst stage were examined. No significant 183 
differences in cleavage were observed among the four oocyte maturation treatment groups (p< 184 
0.05; Fig. 5 and 6).  Likewise, development to the 6-8 cell stage was not significantly influenced 185 
by PTHrP treatment during oocyte maturation (Fig. 5 and 6). However, development to the 186 
blastocyst stage as assessed by the proportion of total oocytes inseminated (Figure 5) or as a 187 
proportion of cleaved zygotes progressing to the blastocyst stage was significantly enhanced 188 
(p<0.05) by the addition of PTHrP to the oocyte maturation medium. The beneficial influence of 189 
PTHrP during oocyte maturation on blastocyst formation arose following the 6-8 cell stage since 190 
PTHrP treatment during oocyte maturation lead to a significant increase (p<0.05) in the 191 
proportion of 6-8 cell zygotes progressing to the blastocyst stage (Figure 6).  192 
193 
 
 10 
DISCUSSION 194 
This study characterized the distribution of mRNAs and polypeptides encoding PTHrP 195 
and the PTHR within bovine ovary and investigated the influence of PTHrP treatment during in 196 
vitro maturation of bovine oocytes on development to the blastocyst stage. The results indicate 197 
that the bovine ovary expresses both the mRNAs encoding PTHrP and PTHR and their 198 
polypeptides. The granulosa layer may be a primary site of PTHrP production (high mRNA 199 
signals) but the majority of this PTHrP does not appear to be stored within the granulosa layer 200 
(low polypeptide signal). Why the granulosa highly expresses PTHrP mRNA but contains little 201 
peptide is unclear. It may be that granulosa PTHrP mRNA is not translated well (or at all) or even 202 
that the PTHrP peptide is secreted to the antral cavity.  The answer to these possibilities awaits 203 
further experimentation. Oocytes from all follicular stages stained intensely for PTHrP 204 
polypeptides. The cognate receptor for PTHrP, the PTHR, was expressed in both oocytes and 205 
granulosa cells of the bovine ovary suggesting that PTHrP may act in both an autocrine and 206 
paracrine fashion to regulate bovine follicle development. PTHrP may also be an important 207 
regulator of oocyte maturation since addition of PTHrP to bovine oocyte maturation medium 208 
enhanced the development of fertilized bovine eggs to the blastocyst stage in vitro.  209 
PTHrP and its receptor, the PTHR, are widely expressed in both skeletal and extraskeletal 210 
tissues (Lee et al., 1995; Urena et. al., 1993; Tian et. al., 1993; Watson et. al, 2000a). Reports 211 
suggest that the distribution of PTHrP and its receptor are nearly ubiquitous since this receptor 212 
ligand duo are described in tissues as diverse as skin (Kaiser et. al., 1992), smooth muscle 213 
(Moseley and Gillespie, 1995; Williams et. al., 1994; Yamamoto et. al., 1992; Watson, et. al., 214 
2000a), bone (Lee et. al., 1993; Kronenberg et. al., 1998), kidney (Lee et. al., 1996; Amizuka et. 215 
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al., 1997; Yang et. al., 1997; Watson, et. al., 2000a), uterus-placenta (Williams et. al., 1994; 216 
Tucci and Beck, 1998; Watson, et. al., 2000b), brain (Weaver et. al., 1995), breast (Downey et. 217 
al., 1997), intestine (Li et. al., 1995; Watson, et. al, 2000a), pancreas and cardiovascular system 218 
(Vasavada, et. al., 1998). Few studies to date have investigated the expression or role of PTHrP 219 
and the PTHR in the mammalian ovary. Ovarian expression of PTHrP was first demonstrated by 220 
the humoral hypercalcemia of malignancy associated with ovarian small cell carcinomas and 221 
PTHrP is now widely used as an ovarian tumour expression marker (Matias-Guiu et. al., 1994; 222 
Inoue et. al., 1995). Northern blots were used to identify PTHR transcripts in rat ovary (Urena et. 223 
al., 1993; Joun et. al., 1997) and PTHrP expression has been demonstrated in the ovary of the 224 
developing frog (Danks et. al., 1997) and most recently in the porcine ovary (Garmey et al., 225 
2000). Both the PTHR and its ligand, PTHrP, have been identified in rat ovary (Watson, et. al, 226 
2000a). Only one study has identified PTHrP as a component of human ovarian follicular fluid 227 
and demonstrated that the granulosa-luteal cells were the source of the PTHrP (Gutmann et. al., 228 
1993).  None of these studies have attempted to localize mRNAs encoding PTHrP and the PTHR 229 
or their polypeptides as we have in the present study. In a recent study reporting nuclear 230 
localization of the PTHR, we observed that transcripts encoding both the PTHR and PTHrP and 231 
their polypeptides were present in rat ovary (Watson et. al., 2000a).  232 
PTHrP is implicated as a regulator of embryo development (Behrendtsen et al.,1995; Lee 233 
et al., 1995; Nowak et al., 1999). PTHrP and the PTHR are expressed during differentiation of 234 
embryonal carcinoma or stem cells to primitive and parietal endoderm (van de Stolpe et. al., 235 
1993) and PTHrP is essential to the outgrowth of parietal endoderm from isolated mouse embryo 236 
inner cell mass (ICM) regardless of the substratum used for outgrowth (Behrendtsen et al., 1995). 237 
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In the developing mouse embryo, expression of PTHR transcripts was detected in parietal 238 
endoderm from day 5.5 p.c. onwards. In the embryo proper, PTHR transcripts were highly 239 
expressed at sites of epithelial-mesenchyme interaction in developing intestine, lung, kidney and 240 
dermis starting at day 9.5 p.c. (Karperien, et. al., 1994).  A comprehensive survey of PTHrP and 241 
PTHR expression during rat fetal development found that, in extraskeletal tissues, PTHrP mRNA 242 
was largely expressed in surface epithelia while PTHR mRNA was mainly localized to the 243 
adjacent mesenchyme (Lee et al., 1995). This was true for tissues as diverse as lung, choroid 244 
plexus, teeth, heart and skin. These results are strongly suggestive of a paracrine role for PTHrP 245 
during development. It has been proposed that PTHrP is a local, autocrine/paracrine regulator of 246 
cell growth and differentiation (Tucci and Beck, 1998; Moseley and Gillespie, 1995). A 247 
physiological role for PTHrP during mammalian endochondral bone formation and modeling is 248 
well documented (Lee, et.al., 1996; Lanske et. al., 1996; Lanske and Kronenberg, 1998). In other 249 
tissues PTHrP regulates smooth muscle relaxation, placental calcium transfer, breast 250 
development and lactation, vascular smooth muscle tension and pancreatic -cell growth (Mosely 251 
and Gillespie, 1995; Vasavada et. al., 1998; Porter et. al., 1998).  Very recently Nowak, et al., 252 
(1999) reported that PTHrP and transforming growth factorTGF-) both interact to promote 253 
murine blastocyst outgrowth demonstrating that PTHrP may be an important regulator of early 254 
developmental events.  255 
The characterization of optimized culture conditions for mammalian oocytes and early 256 
embryos is an important priority. Progress in the development of effective defined media for 257 
embryo culture has occurred rapidly in the last few years. Media supplements such as serum 258 
have, however, only recently been removed from standard culture protocols and little research has 259 
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investigated the role of ovarian factors on oocyte maturation and early development in vitro under 260 
defined serum-free culture conditions (Saeki et al., 1991; Gardner, 1994; Eckert et al., 1995; 261 
Keskintepe and Brackett, 1996; Hill et al., 1997; Avery et al., 1998; Krishner and Bavister, 1999; 262 
Watson et al., 2000). Research from our laboratories has characterized cSOFMaa medium for 263 
bovine oocyte maturation (Watson et al., 2000). Our results indicate that supplementation of 264 
cSOFMaa oocyte maturation medium with PTHrP  may be of benefit for supporting enhanced 265 
numbers of bovine zygotes through to the blastocyst stage.  Future studies will explore the 266 
mechanism underlying this positive influence and will determine whether PTHrP should become 267 
a routine supplement to mammalian oocyte maturation and embryo culture media. 268 
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Figure 1: Detection of PTHrP mRNA in bovine ovary.  Representative photomicrographs 514 
display A) sense control, B) detection of PTHrP mRNAs in primordial follicles included oocytes 515 
and pre-granulosa cells (arrowheads), C) sense control, D) PTHrP mRNAs in oocyte (o) and 516 
granulosa(g) layer of a secondary follicle and stromal (s) tissue, E) PTHrP mRNAs in granulosa 517 
and theca (t) cell layers of antral follicles (a), F) PTHrP mRNAs in oocyte, granulosa cells, and 518 
theca of antral follicles. Bar = 50 M. 519 
 520 
Figure 2: Detection of PTHR mRNAs in bovine ovary. Representative photomicrographs 521 
display A) sense control, B) detection of PTHR mRNAs in primordial follicles included oocytes 522 
and pre-granulosa cells (arrowheads), C) sense control, D) PTHR mRNAs in oocyte (o) and 523 
granulosa (g) layer of primordial and secondary follicles and stromal (s) tissue, E) PTHR mRNAs 524 
in granulosa and theca (t) layers of antral (a) follicles, F) PTHR mRNAs in oocyte, granulosa 525 
cells, and theca of early antral follicle. Bar = 50 M 526 
 527 
Figure 3: Detection of PTHrP polypeptides in bovine ovary The photomicrographs represent 528 
A) mouse normal serum control, B) detection of PTHrP polypeptides in primordial follicles 529 
included oocytes and pre-granulosa cells (arrowheads), C) control, D) PTHrP polypeptides in 530 
oocyte (o) of secondary follicle, E) PTHrP polypeptides in theca (t) layers of antral follicles, F) 531 
PTHrP polypeptides in oocyte of early antral (a) follicle and in ovarian stroma (s). g, granulosa 532 
Bar = 50 M.  533 
 534 
 535 
 536 
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 537 
Figure 4: Detection of PTHR polypeptide in bovine ovary The photomicrographs represent A) 538 
pre-absorbed control, B) detection of PTHR polypeptides in primordial follicles included oocytes 539 
and pre-granulosa cells (arrowheads) and ovarian stroma (s), C) control, D) PTHR polypeptides 540 
in oocyte (o) and granulosa (g) cells of secondary follicle and stromal tissue, E) PTHR 541 
polypeptides in granulosa and theca (t) layers of antral (a) follicles and stroma, F) PTHR 542 
polypeptides in oocyte, granulose cells and theca of antral follicle. Bar = 50 M 543 
 544 
 545 
Figure 5: Influence of  PTHrP during oocyte maturation on blastocyst development. 546 
Proportion of inseminated oocytes cleaving (cleavage), or reaching the 6-8 cell stage, 6-8/insem, 547 
or morula and blastocyst stage of development, mor/bl/insem and blastocysts blast/insem 548 
displayed by oocytes matured in 0, 1.59, 15.9, and 159 ng/ml (0, 0.1, 1 and 10 nM, respectively) 549 
of human PTHrP (1-141)–supplemented cSOFMaa. Cleavage, development to the 6-8 cell and 550 
morulae /blastocyst stages did not vary significantly among the treatment groups. The proportion 551 
of zygotes that progressed to the blastocyst stage varied significantly among the treatments.  Bars 552 
represent the mean  SEM of n=4  replicates. Values with different superscript letters are 553 
significantly different (p<0.05). 554 
555 
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Figure 6: Influence of PTHrP during oocyte maturation on progression of 6-8 cell embryos 559 
to the blastocyst stage.  Proportion of 6-8 cell stage embryos (over cleaved embryos, 6-8/clvd), 560 
morulae –blastocysts (over cleaved embryos, mor-blast/cleaved) blastocysts (over cleaved 561 
embryos, blast/clvd) and 6-8 cell embryos progressing to the blastocyst stage, (blast/6-8) 562 
displayed by oocytes matured in 0, 1.59, 15.9, and 159 ng/ml (0, 0.1, 1 and 10 nM, respectively) 563 
of murine PTHrP (1-141)–supplemented cSOFMaa. Development to the 6-8 cell and morula-564 
blastocyst stages did not vary significantly among the treatment groups. However the proportion 565 
of blastocysts and 6-8 cell embryos that progressed to the blastocyst stage varied significantly. 566 
Bars represent the mean  SEM of n=4  replicates. Values with different superscript letters are 567 
significantly different (p<0.05). 568 
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